Navigation Links
Survivors of childhood polio do well decades later as they age

Mayo Clinic researchers have found that years after experiencing childhood polio, most survivors do not experience declines greater than expected in their elderly counterparts, but rather experience only modest increased weakness which may be commensurate with normal aging.

"Other researchers have suggested that polio is a more aggressive condition later in life, but we've actually found it to be relatively benign," says Eric Sorenson, M.D., Mayo Clinic neurologist and lead study researcher. "Our results suggest that polio survivors may not age any differently than those in the normal population -- they're not doing too badly compared to their peers. This tells us that the cause for the decline in muscle strength in polio survivors may be aging alone."

Polio is a contagious, viral illness that peaked in the United States in 1952, when 3,000 people died of the disease. Mass immunizations in the mid-1950s began to slow the spread of the disease, and the last case of polio not caused by a vaccine occurred in the United States in 1979. The three major types of polio include spinal polio, a paralytic polio that attacks nerve cells in the spinal cord; bulbar polio, in which the virus attacks motor neurons in the brainstem; and bulbospinal polio, a combination of spinal and bulbar polios. The effects of polio run the gamut from a complete return to normal function to paralysis of limbs to acute death. Following the illness, most patients are worried about their long-term prognoses, according to Dr. Sorenson.

To conduct this study, the researchers randomly selected a group of 50 polio survivors from the general population of Olmsted County, home of Mayo Clinic, and followed them for 15 years. The average age of participants at the study's start was 53, and the patients were an average of 40 years past their childhood experience with polio. The researchers measured strength and loss of neurons at the beginning of this period, and then again five a
'"/>

Source:Mayo Clinic


Page: 1 2

Related biology news :

1. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
2. Emergence of cancer as major cause of childhood death in developing countries is not being adequately addressed
3. UCLA researchers identify key enzyme linked to childhood blindness
4. Large-scale genomics project will hunt genes behind common childhood diseases
5. Mother knows best: Plant knowledge key to childhood health in remote Amazon
6. 20-year study shows significant rise in childhood obesity, especially among girls
7. New study challenges critical period in childhood vision development
8. First clinical trial of gene therapy for childhood blindness
9. UN pours polio vaccine into Yemen amid outbreak
10. Billions of dollars saved in US by polio vaccination
11. Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer

Post Your Comments:
(Date:11/24/2009)...en prescribed by traditional healers in Brazil to ...ch pain to fever and flu. , Now for the first tim...ble to scientifically prove the pain relieving pro...azilian mint. , Testing this ancient South Americ...la Rocha was able to show that when prepared as a ...
(Date:11/24/2009)...rotein that may help gut bacteria bind to the gast...robiotic producers to identify strains that are li...cs need to interact with cells lining the gut to h...faces in the gut they are more likely to stick aro...Nathalie Juge from the Institute of Food Research....
(Date:11/24/2009)...e of Medical Toxicology (ACMT) have signed an agre...urnal of Medical Toxicology (JMT), the official j...as previously published by the University of Penns...logy , an international, peer-reviewed journal, is...f medical toxicology. The quarterly journal focus...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Life and Legacy of Philanthropist Theresa Lang Remembered at New York Hospital Queens Gala 47978 1Life and Legacy of Philanthropist Theresa Lang Remembered at New York Hospital Queens Gala 47978 2Crowded emergency departments pose greater risks for patients with heart attacks 47973 1Crowded emergency departments pose greater risks for patients with heart attacks 47973 2Crowded emergency departments pose greater risks for patients with heart attacks 47973 3Scientists tackle the mystery of white nose syndrome in bats 8725 1Scientists tackle the mystery of white nose syndrome in bats 8725 2Scientists tackle the mystery of white nose syndrome in bats 8725 3
..., GAINESVILLE, Fla. --- The observation that male... since 19th century biologist Charles Darwin noted...son with the plainness of the peahens. , No matte...eatures and more melodious warbles in an eternal c...as sexual selection. , Why males are in evolution...
..., As world leaders prepare to discuss conservatio...nitiative threatens a new wave of deforestation in... University of East Anglia and Brazils Goeldi Muse...nce of primary rain forest. , Working in the nor... of scientists undertook the single-largest assess...
..., ,HANOVER, NH -- A team of Dartmouth Medical S...ses of arsenic disrupt the activity of a hormone c...dence that arsenic at low doses (at levels found i...l. The study appeared in the Oct. 26, 2007, online...ectives (EHP), and it will be published in a forth...
Other Biology News:Simple reason helps males evolve more quickly 2Simple reason helps males evolve more quickly 3Single-largest biodiversity survey says primary rainforest is irreplaceable 2Dartmouth researchers show effects of low dose arsenic on development 2
(Date:11/25/2009)....25/PRNewswire-Asia/--SinovacBiotechLtd.(SVA),ale...thatitexecuted,ajointventure(JV)agreementtoestabli...cDalian).TheJVwillresearch,develop,produce,andcomm...sexpertise,andexperienceindevelopingandcommerciali...landuserights,manufacturingfacilitiesand,establish...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...,Who: David Appia, French Ambassador for Internati...t in France Agency, , , , ,What: Ambassador Appia... pro-business initiatives adopted by France to fur...ndscape for innovation and development., , ,When: ...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Sigma-AldrichCorporati...ferenceonTuesday,December1stat1:45PMGMTinLondon,7:...roadcastovertheInternetavailableat http://inve s..."Webcast"icontoaccessthisfile. ,, AboutSigma-...hTechnologycompany.Itschemicalandbiochemicalproduc...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe...pprovedthe,investigationalnewdrugapplication(IND)f...informulationtotreatdiabetes.ThisIND,approvalallow..., Diabetesisadisordercharacteristicofhighbloodgl...oftenresultinseveremicro-and,macro-vasculardisease...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...c Data Presented at 21st North American Cystic Fib...n Adult population -, SOUTH PLAINFIELD, N.J., Oct... a biopharmaceutical company focused on the discov...lecule drugs targeting,post-transcriptional contro...m a Phase 2 clinical trial of PTC124 in pediatric ...
...Md., Oct. 5 Iomai Corporation,(Nasdaq: IOMI ) to...president and chief executive officer, will presen...ce in New York City on Monday, October 8.,Mr. Erck...me in the in,Union Square Room of the Carlton Hote...uent archived recording,log on to the Investor Rel...
...o Include the Recently Released Strong Results fro...he AppyScore Human Appendicitis ...olo., Oct. 5 AspenBio Pharma,Inc. (Nasdaq: APPY ... to the,development of novel drugs and diagnostics...nt at the Oppenheimer Best Ideas 1x1 Conference, s...
Other Biology Technology:PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 2PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 3PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 4PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 5AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference 2AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference 3
...environmental and pathophysiological stressful con...ins known as heat shock proteins (HSPs), more appr...). The Hsp90 family of proteins in mammalian cell...p-1 (Hsp75). It was found that human TRAP-1 is loc...
...poke, cost-effective solutions for complex protein...e our extensive expertise and experience to help y...quely, you may: , , do additional work/sc...all methodology to your own lab , transfer al...
...y Team The Schleicher & Schuell BioScience Arrayi... to custom protein and nucleic acid array manufact...mprised of R&D, Engineering, QC, Planning and Mark...rs every step of the way from feasibility, through...
...mino acid synthetic peptide whose sequences are de...f this peptide is (amino to carboxy terminus): S(2... - K - K - I - K - Q - D - C(39). This peptide m...nts with the polyclonal antibody that reacts with ...
Biology Products: